siRNA targeting Vascular Endothelial Growth Factor (VEGF) has shown promise in suppressing tumor growth in lung cancer, while pDNA nanoparticles withstand the pulmonary environment, proving viable for treating respiratory diseases [53]. This evidence concerns the gene VEGFA and lung carcinoma.